Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KRRO | KORRO BIO INC | $165.86M | 14,422,571 | 29.10% | 70.90% | Net Buying | Net Selling | ||
| CRVO | CERVOMED INC | $26.02M | 9,258,719 | 2.43% | 97.57% | Net Buying | Net Buying | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $537.40M | 52,276,254 | 80.12% | 19.88% | Net Selling | Net Selling | ||
| KYMR | KYMERA THERAPEUTICS INC | $8.68B | 82,257,588 | 78.37% | 21.63% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $2.03B | 47,826,929 | 77.47% | 22.53% | Net Selling | Net Selling | ||
| TFII | TFI INTERNATIONAL INC | $11.46B | 82,193,031 | 69.31% | 0.00% | ||||
| ALM | ALMONTY INDUSTRIES INC | $3.50B | 262,776,228 | 36.74% | 0.00% | ||||
| DSGN | DESIGN THERAPEUTICS INC | $849.23M | 62,581,651 | 48.28% | 51.72% | Net Selling | |||
| MSLE | SATELLOS BIOSCIENCE INC | $208.52M | 20,831,190 | 38.33% | 0.00% | ||||
| VEL | VELOCITY FINANCIAL INC | $693.64M | 39,255,281 | 44.45% | 55.55% | Net Buying | Net Buying | ||
| ASST | STRIVE INC | $909.88M | 73,082,631 | 14.33% | 85.67% | Net Buying | |||
| LONA | LEONABIO INC | $72.14M | 9,393,514 | 34.44% | 65.56% | Net Buying | |||
| CLS | CELESTICA INC | $41.71B | 114,982,086 | 65.67% | 1.34% | Net Selling | Net Selling | ||
| HELP | CYBIN INC | $543.68M | 51,631,804 | 46.70% | 0.00% | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $528.63M | 61,184,313 | 21.83% | 35.74% | Net Selling | Net Selling | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $177.31M | 18,527,795 | 46.35% | 53.65% | Net Selling | Net Buying | ||
| ATOS | ATOSSA THERAPEUTICS INC | $20.58M | 8,611,361 | 10.92% | 89.08% | ||||
| SKHY | SK HYNIX INC | N/A | 728,865,500 | 0.00% | 0.00% | ||||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $177.93M | 28,423,069 | 85.46% | 12.98% | Net Buying | |||
| DEFT | DEFI TECHNOLOGIES INC | $186.13M | 387,777,239 | 7.17% | 0.00% | ||||
| FTH | FAETH THERAPEUTICS INC | $635.42M | 25,840,425 | 8.35% | 30.96% | Net Buying | Net Buying | ||
| OSTX | OS THERAPIES INC | $71.26M | 44,538,106 | 6.51% | 14.34% | ||||
| VOR | VOR BIOPHARMA INC | $1.21B | 54,185,877 | 70.12% | 29.88% | Net Selling | Net Buying | ||
| LTRX | LANTRONIX INC | $234.52M | 39,816,930 | 9.82% | 90.18% | Net Selling | Net Selling | ||
| WHWK | WHITEHAWK THERAPEUTICS INC | $201.27M | 49,452,463 | 43.04% | 56.96% | Net Buying | Net Buying | ||
| BNTX | BIONTECH SE | $23.31B | 252,884,261 | 18.79% | 16.46% | Net Selling | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $759.50M | 267,430,821 | 30.52% | 1.13% | Net Selling | Net Selling | ||
| GT | GOODYEAR TIRE & RUBBER CO | $1.99B | 287,438,631 | 94.05% | 1.80% | Net Selling | Net Selling | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $553.43M | 17,755,284 | 64.85% | 19.96% | Net Selling | Net Selling | ||
| AVAV | AEROVIRONMENT INC | $8.51B | 50,608,030 | 40.13% | 59.87% | Net Selling | Net Selling | ||
| VIA | VIA TRANSPORTATION INC | $1.74B | 81,295,871 | 47.19% | 34.92% | Net Selling | Net Buying | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.34B | 103,652,656 | 84.67% | 15.33% | Net Selling | Net Selling | ||
| BTGO | BITGO HOLDINGS INC | $579.80M | 115,959,409 | 30.56% | 12.79% | Net Selling | Net Selling | ||
| RLMD | RELMADA THERAPEUTICS INC | $570.60M | 104,890,223 | 79.76% | 3.37% | Net Buying | |||
| SPRB | SPRUCE BIOSCIENCES INC | $128.28M | 2,752,278 | 3.89% | 96.11% | Net Selling | Net Buying | ||
| CSTL | CASTLE BIOSCIENCES INC | $928.71M | 30,549,507 | 85.25% | 14.75% | Net Selling | Net Selling | ||
| XE | X-ENERGY INC | $5.48B | 287,458,734 | 0.00% | 36.81% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.